ESR1 and breast cancer: Furthermore, as described in MCF7 tumor cell line and in a xenografts model, the breast cancer molecular subtype, particularly the different isoforms of Estrogen Receptor α may modulate by vitamin D signaling and in response to vitamin D supplementation [29].